Tegaserod and Placebo
ApprovedWithdrawn 1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Constipation and Dyspepsia
Conditions
Constipation and Dyspepsia
Trial Timeline
— → —
NCT ID
NCT00277550About Tegaserod and Placebo
Tegaserod and Placebo is a approved stage product being developed by Novartis for Constipation and Dyspepsia. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00277550. Target conditions include Constipation and Dyspepsia.
What happened to similar drugs?
20 of 20 similar drugs in Constipation and Dyspepsia were approved
Approved (20) Terminated (4) Active (0)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00277550 | Approved | Withdrawn |
Competing Products
20 competing products in Constipation and Dyspepsia